Nigella Sativa and thymoquinone suppress cyclooxygenase-2 and oxidative stress in pancreatic tissue of streptozotocin-induced diabetic rats

Pancreas

Volumn 42, Issue 5, 2013, Pages 841-849

  Al Wafai, Rana J ^a  

^a BEIRUT ARAB UNIVERSITY   (Lebanon)

Author keywords

Cyclooxygenase 2; Intracellular adhesion molecule; Nigella sativa; Streptozotocin; Thymoquinone; Type 1 diabetes

Indexed keywords

CYCLOOXYGENASE 2; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; NIGELLA SATIVA EXTRACT; SUPEROXIDE DISMUTASE; THYMOQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; GENE EXPRESSION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANALYSIS OF VARIANCE; ANIMALS; BENZOQUINONES; CYCLOOXYGENASE 2; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; INTERCELLULAR ADHESION MOLECULE-1; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NIGELLA SATIVA; OXIDATIVE STRESS; PANCREAS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 84880051620     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318279ac1c     Document Type: Article

References (43)

1. Cnop M, Welsh N, Jonas J.C., et al Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005;54(suppl 2):S97-S107.
2. Expert Committee on the D, Classification of Diabetes M. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S5-S20.
3. Permutt MA, Wasson J, Cox N. Genetic epidemiology of diabetes. J Clin Invest. 2005;115:1431-1439.
4. Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med. 2001;249:225-235.
5. Daneman D. Type 1 diabetes. Lancet. 2006;367:847-858.
6. Mendola J, Wright JR Jr, Lacy PE Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitis. Diabetes. 1989;38:379-385.
7. Rabinovitch A, Suarez-Pinzon WL, Strynadka K., et al Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab. 1996;81:3197-3202.
8. Pirot P, Cardozo AK, Eizirik DL Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes. Arq Bras Endocrinol Metabol. 2008;52:156-165.
9. Callejas NA, Casado M, Bosca L., et al Requirement of nuclear factor kappaB for the constitutive expression of nitric oxide synthase-2 and cyclooxygenase-2 in rat trophoblasts. J Cell Sci. 1999;112(Pt 18):3147-3155.
10. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 1994;10:405-455.
11. Jobin C, Morteau O, Han D.S., et al Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology. 1998;95:537-543.
12. Marnett LJ. Cyclooxygenase mechanisms. Curr Opin Chem Biol. 2000;4:545-552.
13. Tabatabaie T, Vasquez AM, Moore D.R., et al Direct administration of interleukin-1 and interferon-gamma to rat pancreas leads to the in vivo production of nitric oxide and expression of inducible nitric oxide synthase and inducible cyclooxygenase. Pancreas. 2001;23:316-322.
14. Tabatabaie T, Vasquez-Weldon A, Moore D.R., et al Free radicals and the pathogenesis of type 1 diabetes: beta-cell cytokine-mediated free radical generation via cyclooxygenase-2. Diabetes. 2003;52:1994-1999.
15. Kwon G, Corbett JA, Hauser S, et al Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes. 1998;47:583-591.
16. McDaniel ML, Kwon G, Hill J.R., et al Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med. 1996;211:24-32.
17. Litherland SA, Xie XT, Hutson A.D., et al Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest. 1999;104:515-523.
18. Ganapathy V, Gurlo T, Jarstadmarken H.O., et al Regulation of TCR-induced IFN-gamma release from islet-reactive non-obese diabetic CD8(+) T cells by prostaglandin E(2) receptor signaling. Int Immunol. 2000;12:851-860.
19. Tabatabaie T, Waldon AM, Jacob J.M., et al COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice. Biochem Biophys Res Commun. 2000;273:699-704.
20. Martin S, van den Engel NK, Vinke A, et al. Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. J Autoimmun. 2001;17:109-117.
21. Augstein P, Dunger A, Heinke P., et al Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells. Biochem Biophys Res Commun. 2003;304:378-384.
22. Camacho SA, Heath WR, Carbone F.R., et al A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol. 2001;2:523-529.
23. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51:216-226.
24. Houghton PJ, Zarka R, de las Heras B, et al. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 1995;61:33-36.
25. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17:299-305.
26. Mahgoub AA. Thymoquinone protects against experimental colitis in rats. Toxicol Lett. 2003;143:133-143.
27. Hajhashemi V, Ghannadi A, Jafarabadi H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother Res. 2004;18:195-199.
28. El-Mahmoudy A., Shimizu Y, Shiina T., et al Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone. Acta Diabetol. 2005;42:23-30.
29. El Gazzar M., El Mezayen R, Marecki JC, et al Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int Immunopharmacol. 2006;6:1135-1142.
30. Kanter M, Meral I, Yener Z., et al Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp Med. 2003;201:213-219.
31. Abassi Z, Brodsky S, Gealekman O., et al Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure. Am J Physiol Renal Physiol. 2001;280:F43YF53.
32. Li YY, Li XL, Yang C.X., et al Effects of Tetrandrine and QYT on ICAM-1 and SOD gene expression in pancreas and liver of rats with acute pancreatitis. World J Gastroenterol. 2003;9:155-159.
33. Feliers D, Duraisamy S, Barnes J.L., et al Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am J Physiol Renal Physiol. 2005;288:F521YF529.
34. Noonan KE, Roninson IB mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Res. 1988;16:10366.
35. Ukeda H, Maeda S, Ishii T., et al Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3'-1-(phenylamino)-carbonyl-3, 4-tetrazolium]-bis(4-methoxy-6-nitro)benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase. Anal Biochem. 1997;251:206-209.
36. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
37. Yuan HD, Chung SH Fermented ginseng protects streptozotocin-induced damage in rat pancreas by inhibiting nuclear factor-kappaB. Phytother Res. 2010;24(suppl 2):S190-S195.
38. El Mezayen R., El Gazzar M, Nicolls MR, et al Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett. 2006;106:72-81.
39. Marsik P, Kokoska L, Landa P., et al In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med. 2005;71:739-742.
40. Chehl N, Chipitsyna G, Gong Q., et al Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford). 2009;11:373-381.
41. Kanter M, Coskun O, Korkmaz A., et al Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats. Anat Rec A Discov Mol Cell Evol Biol. 2004;279:685-691.
42. Meral I, Yener Z, Kahraman T., et al Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits. J Vet Med A Physiol Pathol Clin Med. 2001;48:593-599.
43. Abdelmeguid NE, Fakhoury R, Kamal S.M., et al Effect of Nigella sativa L. and thymoquinone on streptozotocin induced cellular damage in pancreatic islets of rats. Asian J Cell Biol. 2011;6:1-21.